BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28548185)

  • 1. [Evaluation the American College of Cardiology and American Heart Association Predictive score for cardiovascular diseases].
    Acevedo M; Valentino G; Kramer V; Bustamante MJ; Adasme M; Orellana L; Baraona F; Navarrete C
    Rev Med Chil; 2017 Mar; 145(3):292-298. PubMed ID: 28548185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
    Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
    Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
    Echeverría G; Dussaillant C; Villarroel L; Rigotti A
    J Clin Lipidol; 2016; 10(1):192-8.e1. PubMed ID: 26892136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.
    Kawai VK; Chung CP; Solus JF; Oeser A; Raggi P; Stein CM
    Arthritis Rheumatol; 2015 Feb; 67(2):381-5. PubMed ID: 25371313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
    Jafri K; Ogdie A; Qasim A; Patterson SL; Gianfrancesco M; Izadi Z; Katz P; Yazdany J; Schmajuk G
    Clin Rheumatol; 2018 Feb; 37(2):467-474. PubMed ID: 28993952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
    Tournadre A; Tatar Z; Pereira B; Chevreau M; Gossec L; Gaudin P; Soubrier M; Dougados M
    Int J Cardiol; 2015 Mar; 183():149-54. PubMed ID: 25666124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorespiratory fitness improves prediction of mortality of standard cardiovascular risk scores in a Latino population.
    Acevedo M; Valentino G; Bustamante MJ; Orellana L; Adasme M; Baraona F; Corbalán R; Navarrete C
    Clin Cardiol; 2020 Oct; 43(10):1167-1174. PubMed ID: 32692414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
    Ofori S; Dodiyi-Manuel S; Akpa MR
    J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
    Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
    Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Lato V; Becciolini A; Favalli EG; Giovagnoni A
    Swiss Med Wkly; 2018 Aug; 148():w14656. PubMed ID: 30141517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new "intermediate risk" group: a comparative analysis of the new 2013 ACC/AHA risk assessment guidelines versus prior guidelines in men.
    Blaha MJ; Dardari ZA; Blumenthal RS; Martin SS; Nasir K; Al-Mallah MH
    Atherosclerosis; 2014 Nov; 237(1):1-4. PubMed ID: 25173946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention.
    Krone RJ; Laskey WK; Johnson C; Kimmel SE; Klein LW; Weiner BH; Cosentino JJ; Johnson SA; Babb JD
    Am J Cardiol; 2000 May; 85(10):1179-84. PubMed ID: 10801997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Sacco RL; Roth GA; Reddy KS; Arnett DK; Bonita R; Gaziano TA; Heidenreich PA; Huffman MD; Mayosi BM; Mendis S; Murray CJ; Perel P; Piñeiro DJ; Smith SC; Taubert KA; Wood DA; Zhao D; Zoghbi WA
    Circulation; 2016 Jun; 133(23):e674-90. PubMed ID: 27162236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol treatment and changes in guidelines in an academic medical practice.
    Schoen MW; Salas J; Scherrer JF; Buckhold FR
    Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients.
    Pinto Neto LFDS; Dias FR; Bressan FF; Santos CRO
    Braz J Infect Dis; 2017; 21(6):577-580. PubMed ID: 28732190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study.
    Barua L; Faruque M; Banik PC; Ali L
    Medicina (Kaunas); 2019 Jun; 55(7):. PubMed ID: 31248050
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.